Abstract:Microvesicles (MVs) derived from bronchopulmonary dysplasia (BPD) show a negative lung simplification role through complex gene networks, and miR139‐3p, miR6125 and miR193b‐3p are significantly enriched in MVs. Among them, miR139‐3p may be the most critical molecule in MVs affecting lung simplification. These findings may facilitate the identification of the role of MVs in the pathological of BPD and the treatment of BPD based on MVs' strategies. Background Microvesicles (MVs) play a crucial role in bronchopulmonary dysplasia (BPD). There are many MVs in circulating plasma, and they are in direct contact with lung endothelial cells. However, the molecular mechanism and causative effect of circulating MVs on BPD remain unclear. Methods Clinical plasma samples were collected, circulating MVs were isolated, and microRNA (miRNA) sequencing was performed. The BPD model was established, and different MVs were administered. Alveoli and pulmonary vessels were examined by hematoxylin–eosin staining, and body weight and length were measured. In vitro, gene expression was disrupted by miRNA mimics, miRNA inhibitors or plasmid transfection. Cell proliferation and protein expression were detected by cell scratch assay, accurate 5‐ethynyl‐2‐deoxyuridine test, western blotting, or immunofluorescence assay. Results BPD‐derived MVs further aggravated pulmonary vascular simplification, while circulating MVs from control mice mitigated pulmonary vascular simplification. Micro‐RNA sequencing and independent sample verification revealed that miR139‐3p, but not miR6125 or miR193b‐3p, was the most critical effector molecule in MVs. Mechanism studies showed that eukaryotic translation initiation factor 4E binding protein 1 was the target gene for miR139‐3p. In addition, we found that supplementation of miR139‐3p inhibitor partially alleviated pulmonary vascular simplification. Conclusions These results indicate that circulating MVs are involved in forming BPD by carrying miR139‐3p molecules and support miR139‐3p inhibitors as a potential therapeutic strategy for alleviating pulmonary vascular simplification in BPD.

Impaired Myofibroblast Proliferation is a Central Feature of Pathologic Post-Natal Alveolar Simplification

Aberrant signaling pathways of the lung mesenchyme and their contributions to the pathogenesis of bronchopulmonary dysplasia.

Lipopolysaccharide Disrupts the Directional Persistence of Alveolar Myofibroblast Migration Through EGF Receptor.

Myofibroblast Contraction is Essential for Generating and Regenerating the Gas-Exchange Surface.

Disrupted TGF-β signaling: a link between bronchopulmonary dysplasia and alveolar type 1 cells

Csk/Src/EGFR Signaling Regulates Migration of Myofibroblasts and Alveolarization.

Circulating microvesicles miR139‐3p from bronchopulmonary dysplasia aggravates pulmonary vascular simplification by targeting 4E binding protein 1

Alteration of TGF-β-ALK-Smad Signaling in Hyperoxia-Induced Bronchopulmonary Dysplasia Model of Newborn Rats.

TGF-α/EGFR signaling promotes lipopolysaccharide-induced abnormal elastin deposition and alveolar simplification

Tenascin-C modulates alveolarization in bronchopulmonary dysplasia

Bronchopulmonary Dysplasia with Pulmonary Hypertension Associates with Loss of Semaphorin Signaling and Functional Decrease in FOXF1 Expression

TGF-β controls alveolar type 1 epithelial cell plasticity and alveolar matrisome gene transcription in mice

Decoding the IGF1 signaling gene regulatory network behind alveologenesis from a mouse model of bronchopulmonary dysplasia

YAP and Wnt3a Independently Promote AECIIs Proliferation and Differentiation by Increasing Nuclear Β‑catenin Expression in Experimental Bronchopulmonary Dysplasia

The pentose phosphate pathway mediates hyperoxia-induced lung vascular dysgenesis and alveolar simplification in neonates

Conditional overexpression of TGFβ1 promotes pulmonary inflammation, apoptosis and mortality via TGFβR2 in the developing mouse lung

Role of Myeloperoxidase, Oxidative Stress, and Inflammation in Bronchopulmonary Dysplasia

Reinitiating lung development: a novel approach in the management of bronchopulmonary dysplasia

Molecular mechanisms of cell death in bronchopulmonary dysplasia

Signaling Pathways Involved in the Development of Bronchopulmonary Dysplasia and Pulmonary Hypertension